Abstract
BackgroundRisperidone (RSP) has a rapid onset in vivo, low dosage and high plasma protein binding rate, therefore therapeutic drug monitoring (TDM) is needed to ensure safety in clinical treatment. However,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have